Ticker Details
Innovus Pharmaceuticals Inc
IPO Date:	March 4, 2021
Sector:	Healthcare
Industry:	Medical Care Facilities
Market Cap:	$977.3M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 3.14%
Avg Daily Range (30 D):	$0.17 | 2.17%
Avg Daily Range (90 D):	$0.22 | 2.79%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	121
Avg Institutional Trade:	$2.53M
Avg Institutional Trade (30 D):	$.61M
Avg Institutional Trade (90 D):	$.75M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.34M
Avg Closing Trade (30 D):	$.61M
Avg Closing Trade (90 D):	$.67M
Avg Closing Volume:	226.11K

News

Apr 21, 2026 @ 12:00 PM InnovAge to Announce Fiscal Third Quarter 2026 Fin... Source: Na

Dec 11, 2025 @ 9:43 PM Court Approves $27M Cash Settlement in InnovAge Se... Source: Cohen Milstein Sellers & Toll Pllc

Sep 9, 2025 @ 11:19 PM InnovAge Revenue Jumps 11% in Fiscal Q4 Source: Motley Fool Markets Team

Jul 21, 2025 @ 1:00 PM Cohen Milstein Sellers & Toll PLLC Announces Propo... Source: Cohen Milstein Sellers & Toll Pllc

Aug 22, 2024 @ 7:20 PM CORRECTION -- InnovAge PACE Celebrates Anniversary... Source: Clear® Verified

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-.08	$-.22	$.08
Diluted EPS	$-.08	$-.22	$.08
Revenue	$949.17M	$251.94M	$239.71M
Gross Profit	$206.49M	$61.02M	$52.83M
Net Income / Loss	$-15.48M	$-29.94M	$11.81M
Operating Income / Loss	$-9.68M	$-29.08M	$13.26M
Cost of Revenue	$300.41M	$77.68M	$74.88M
Net Cash Flow	$36.22M	$12.33M	$16.06M
PE Ratio

Splits
Mar 18, 2019	1:105